| Authors: |
Zou Y; Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, Pennsylvania., Watters A; Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, Pennsylvania., Cheng N; Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, Pennsylvania., Perry CE; Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, Pennsylvania., Xu K; MD/PhD Program, Boston University School of Medicine, Boston, Massachusetts., Alicea GM; Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, Pennsylvania., Parris JLD; Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, Pennsylvania., Baraban E; Departments of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Ray P; Delaware Neurosurgical Group, ChristianaCare Health System, Newark, Delaware., Nayak A; Departments of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Xu X; Departments of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Herlyn M; Melanoma Research Center, The Wistar Institute, Philadelphia, Pennsylvania.; Melanoma Research Center, The Wistar Institute, Philadelphia, Pennsylvania., Murphy ME; Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, Pennsylvania., Weeraratna AT; Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, Pennsylvania., Schug ZT; Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, Pennsylvania., Chen Q; Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, Pennsylvania. qichen@wistar.org. |